IL10 and Huntington disease: Overall, looking at these different molecules, together with other inflammatory markers, we found that HD patients affected by COVID-19, when compared with HD patients without COVID-19, showed some features commonly reported in general COVID-19 patients, including lymphopenia and high levels of ferritin and LDH, associated with an increase in the levels of anti-inflammatory IL-10.